Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
25.04.26
/
50%
€156.48
Target price
25.04.27
€203.01
Performance (%)
16.37%
Price
19.08.26
€189.72
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr currently has a performance of 16.37%. This prediction currently runs until 25.04.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 4.714% | 4.714% |
| iShares Core DAX® | -1.059% | 5.007% |
| iShares Nasdaq 100 | -2.387% | 0.864% |
| iShares Nikkei 225® | -4.361% | 1.211% |
| iShares S&P 500 | -1.778% | 1.391% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) had its price target raised by The Goldman Sachs Group, Inc. from $231.00 to $238.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat